Paragon Health Institute proposes voluntary framework to address AI medical device safety gaps

Paragon Health Institute proposed a voluntary framework May 20 to flag when patient data falls outside an AI medical device's training range. The system aims to close the gap between testing performance and real-world results.

Published on: May 21, 2026
Paragon Health Institute proposes voluntary framework to address AI medical device safety gaps

Paragon Health Institute Proposes Safety Framework for AI Medical Devices

Paragon Health Institute published a research paper May 20 proposing a new approach to one of the central safety problems in AI-enabled medical devices: the gap between how well these systems perform in testing versus how they perform on real patients.

AI medical devices often work reliably during development but behave unpredictably when deployed to patients whose medical images or data differ from the training set. This performance gap, called generalization uncertainty, has no settled solution in current regulatory frameworks.

The Cost Problem With Current Approaches

Existing remedies carry significant drawbacks. High-cost consultations required to validate device performance create barriers for rural hospitals and safety-net providers that lack resources well-financed health systems have. Risk assessments tied to broad demographic categories also fail to account for individual patient variation.

The policy challenge is clear: regulators must avoid mandating solutions that sound safe but actually slow adoption of life-saving technology without meaningfully improving outcomes.

Digital Similarity Analysis: A Voluntary Framework

The paper proposes Digital Similarity Analysis (DSA), a voluntary system manufacturers could implement to flag when a patient's medical data falls outside the range the device was trained on. When DSA alerts a physician to an outlier case, the physician can choose to forgo the device, request additional validation of its output, or use it with reduced confidence.

DSA would not eliminate generalization uncertainty. Instead, it gives clinicians actionable information at the point of care-before a device is used on an atypical patient.

Trade-offs and Broader Implications

The framework preserves manufacturers' training data confidentiality, a critical competitive asset in AI development. It also shifts the conversation about algorithmic bias from population-level demographics to individual patient characteristics, potentially improving safety across demographic groups.

Paragon Health Institute, a nonprofit research organization founded in 2021, does not accept industry funding. The institute has published related work on AI for healthcare, including papers on postmarket surveillance and regulatory guidelines for AI innovation in medicine.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)